2-85663812-G-A

Variant summary

Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_000542.5(SFTPB):​c.708C>T​(p.Arg236=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000589 in 1,599,064 control chromosomes in the GnomAD database, including 10 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00050 ( 2 hom., cov: 32)
Exomes 𝑓: 0.00060 ( 8 hom. )

Consequence

SFTPB
NM_000542.5 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.550
Variant links:
Genes affected
SFTPB (HGNC:10801): (surfactant protein B) This gene encodes the pulmonary-associated surfactant protein B (SPB), an amphipathic surfactant protein essential for lung function and homeostasis after birth. Pulmonary surfactant is a surface-active lipoprotein complex composed of 90% lipids and 10% proteins which include plasma proteins and apolipoproteins SPA, SPB, SPC and SPD. The surfactant is secreted by the alveolar cells of the lung and maintains the stability of pulmonary tissue by reducing the surface tension of fluids that coat the lung. The SPB enhances the rate of spreading and increases the stability of surfactant monolayers in vitro. Multiple mutations in this gene have been identified, which cause pulmonary surfactant metabolism dysfunction type 1, also called pulmonary alveolar proteinosis due to surfactant protein B deficiency, and are associated with fatal respiratory distress in the neonatal period. Alternatively spliced transcript variants encoding the same protein have been identified.[provided by RefSeq, Feb 2010]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.48).
BP6
Variant 2-85663812-G-A is Benign according to our data. Variant chr2-85663812-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 227073.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.55 with no splicing effect.
BS1
Variant frequency is greater than expected in population sas. gnomad4 allele frequency = 0.000499 (76/152332) while in subpopulation SAS AF= 0.011 (53/4834). AF 95% confidence interval is 0.00861. There are 2 homozygotes in gnomad4. There are 48 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
SFTPBNM_000542.5 linkuse as main transcriptc.708C>T p.Arg236= synonymous_variant 7/11 ENST00000519937.7

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
SFTPBENST00000519937.7 linkuse as main transcriptc.708C>T p.Arg236= synonymous_variant 7/111 NM_000542.5 P1
SFTPBENST00000393822.7 linkuse as main transcriptc.708C>T p.Arg236= synonymous_variant 8/121 P1
SFTPBENST00000409383.6 linkuse as main transcriptc.708C>T p.Arg236= synonymous_variant 8/121 P1
SFTPBENST00000428225.5 linkuse as main transcriptc.699C>T p.Arg233= synonymous_variant 7/112

Frequencies

GnomAD3 genomes
AF:
0.000499
AC:
76
AN:
152214
Hom.:
2
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000145
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00327
Gnomad SAS
AF:
0.0110
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00119
AC:
255
AN:
214316
Hom.:
3
AF XY:
0.00155
AC XY:
182
AN XY:
117574
show subpopulations
Gnomad AFR exome
AF:
0.0000788
Gnomad AMR exome
AF:
0.0000312
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00195
Gnomad SAS exome
AF:
0.00769
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000930
GnomAD4 exome
AF:
0.000599
AC:
866
AN:
1446732
Hom.:
8
Cov.:
35
AF XY:
0.000829
AC XY:
596
AN XY:
718816
show subpopulations
Gnomad4 AFR exome
AF:
0.0000903
Gnomad4 AMR exome
AF:
0.0000232
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00338
Gnomad4 SAS exome
AF:
0.00791
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000813
Gnomad4 OTH exome
AF:
0.000903
GnomAD4 genome
AF:
0.000499
AC:
76
AN:
152332
Hom.:
2
Cov.:
32
AF XY:
0.000644
AC XY:
48
AN XY:
74482
show subpopulations
Gnomad4 AFR
AF:
0.000144
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00328
Gnomad4 SAS
AF:
0.0110
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.000299
Hom.:
1
Bravo
AF:
0.000181
Asia WGS
AF:
0.0110
AC:
37
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 14, 2023- -
not specified Benign:1
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineJan 06, 2016p.Arg248Arg in exon 8 of SFTPB: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue and is not located wi thin the splice consensus sequence. It has been identified in 1% of South Asian chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitut e.org; dbSNP rs367661082). -
Surfactant metabolism dysfunction, pulmonary, 1 Benign:1
Benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 13, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -
Hereditary pulmonary alveolar proteinosis Benign:1
Likely benign, criteria provided, single submitterclinical testingAmbry GeneticsMay 05, 2023This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.48
CADD
Benign
9.1
DANN
Benign
0.64

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs367661082; hg19: chr2-85890935; API